治疗组用西药抗生素+激素治疗+通窍鼻炎片治疗。
Antibiotic and incretion were applied in the control group, while TQBYP, Antibiotic and incretion applied to the treatment groups.
为数不多的关于鼻炎片的西方研究结果之一今年早些时候发表。
One of the few Western studies was published earlier this year.
在美国，鼻炎片通过超市、天然食品店或针灸诊所销售，其形式为药片或是味道浓烈的茶饮。
Biyan Pian literally means' nose inflammation pill. 'in the U. S., it is sold in supermarkets and natural-food stores and through acupuncturists either as tablets or as a strongly flavored tea.
经销由11种草药制成的“鼻炎片”的公司说，这种传统中药制剂可以缓解鼻塞、助你呼吸顺畅。
A traditional Chinese mix of 11 herbs called Biyan Pian can relieve congestion and help you breathe easier, according to companies that sell it.
TraditionalMedicinals公司的“呼吸舒畅”茶在鼻炎片配方的基础上加大了甘草的剂量，这种茶的包装上有警示，说明高血压患者不可饮用。
Traditional Medicinals' Breathe Easy tea, in which additional licorice root has been added to the Biyan Pian formula, carries a warning that it shouldn't be used in patients with high blood pressure.
地洛他定片是高效的选择性H_1受体拮抗剂，并且具有抗炎活性，可用于治疗变应性鼻炎和荨麻疹等变应性疾病。
Desloratadine, a new and selective H1-receptor antagonist with anti-inflammatory activity, was used to treat allergic diseases such as allergic rhinitis and urticaria.
目的研究中成药鼻敏片对变应性鼻炎豚鼠血浆中P物质的影响。
Objective To investigate the pharmacological effects of Bimin Tablets (BMT)on substance P (SP) in the plasma of guinea pigs with experimentally induced allergic rhinitis(AR).
结论：地洛他定片治疗过敏性鼻炎安全、有效。
Conclusion: Desloratadine in treating allergic rhinitis is effective and safe.
国产地洛他定片治疗变应性鼻炎疗效可靠、安全性好。
National Desloratadine is effective and safe for allergic rhinitis.
目的观察盐酸司他斯汀片对常年性变应性鼻炎的临床疗效。
Aim To evaluate the efficacy of setastine hydrochloride tablets in treatment of perennial allergic rhinitis patients.
结果盐酸氮革斯汀片和氯雷他定片治疗变应性鼻炎的有效率分别为87.93%，82.54%；药物不良反应发生率分别为8.62%，14.06%。
Results the total effective rate was 87.93% for azelastine group and 82.54% for loratadine group, and the adverse event rate was 8.62% and 14.06%, respectively.
结果盐酸氮革斯汀片和氯雷他定片治疗变应性鼻炎的有效率分别为87.93%，82.54%；药物不良反应发生率分别为8.62%，14.06%。
Results the total effective rate was 87.93% for azelastine group and 82.54% for loratadine group, and the adverse event rate was 8.62% and 14.06%, respectively.
应用推荐